Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - ROCKET PHARMACEUTICALS, INC. | ex31_1.htm |
| EX-32.1 - EXHIBIT 32.1 - ROCKET PHARMACEUTICALS, INC. | ex32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - ROCKET PHARMACEUTICALS, INC. | ex31_2.htm |
| EX-21.1 - EXHIBIT 21.1 - ROCKET PHARMACEUTICALS, INC. | ex21_1.htm |
| EX-10.10 - EXHIBIT 10.10 - ROCKET PHARMACEUTICALS, INC. | ex10_10.htm |
| EX-10.6.1 - EXHIBIT 10.6.1 - ROCKET PHARMACEUTICALS, INC. | ex10_61.htm |
| 10-K - 10-K - ROCKET PHARMACEUTICALS, INC. | form10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Rocket
Pharmaceuticals, Inc. on Form S-3 (No. 333-232168) and Forms S-8 (Nos. 333-204501, 333-212308, 333-216892 and 333-223488) of our report dated March 6, 2020, on our audits of
the consolidated financial statements as of December 31, 2019 and 2018 and for each of the years then ended, which report is included in this Annual Report on Form
10-K to be filed on or about March 6, 2020.
/s/ EISNERAMPER LLP
EISNERAMPER LLP
New York, New York
March 6, 2020